341 related articles for article (PubMed ID: 37896233)
1. Uptake Transporters at the Blood-Brain Barrier and Their Role in Brain Drug Disposition.
Parvez MM; Sadighi A; Ahn Y; Keller SF; Enoru JO
Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896233
[TBL] [Abstract][Full Text] [Related]
2. Recent advance in the pharmacogenomics of human Solute Carrier Transporters (SLCs) in drug disposition.
Zhou F; Zhu L; Wang K; Murray M
Adv Drug Deliv Rev; 2017 Jul; 116():21-36. PubMed ID: 27320645
[TBL] [Abstract][Full Text] [Related]
3.
Zhou S; Shu Y
Drug Metab Dispos; 2022 May; 50(9):1238-50. PubMed ID: 35644529
[TBL] [Abstract][Full Text] [Related]
4. Species differences in drug transporters and implications for translating preclinical findings to humans.
Chu X; Bleasby K; Evers R
Expert Opin Drug Metab Toxicol; 2013 Mar; 9(3):237-52. PubMed ID: 23256482
[TBL] [Abstract][Full Text] [Related]
5. OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies.
Roth M; Obaidat A; Hagenbuch B
Br J Pharmacol; 2012 Mar; 165(5):1260-87. PubMed ID: 22013971
[TBL] [Abstract][Full Text] [Related]
6. Functional Expression of P-glycoprotein and Organic Anion Transporting Polypeptides at the Blood-Brain Barrier: Understanding Transport Mechanisms for Improved CNS Drug Delivery?
Abdullahi W; Davis TP; Ronaldson PT
AAPS J; 2017 Jul; 19(4):931-939. PubMed ID: 28447295
[TBL] [Abstract][Full Text] [Related]
7. Expression and function of organic cation and anion transporters (SLC22 family) in the CNS.
Farthing CA; Sweet DH
Curr Pharm Des; 2014; 20(10):1472-86. PubMed ID: 23789957
[TBL] [Abstract][Full Text] [Related]
8. SLC Family Transporters.
Liu X
Adv Exp Med Biol; 2019; 1141():101-202. PubMed ID: 31571165
[TBL] [Abstract][Full Text] [Related]
9. Blood-Brain Barrier Transporters: Opportunities for Therapeutic Development in Ischemic Stroke.
Nilles KL; Williams EI; Betterton RD; Davis TP; Ronaldson PT
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163820
[TBL] [Abstract][Full Text] [Related]
10. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases.
Löscher W; Potschka H
Prog Neurobiol; 2005 May; 76(1):22-76. PubMed ID: 16011870
[TBL] [Abstract][Full Text] [Related]
11. Membrane transporter proteins: a challenge for CNS drug development.
Girardin F
Dialogues Clin Neurosci; 2006; 8(3):311-21. PubMed ID: 17117613
[TBL] [Abstract][Full Text] [Related]
12. Organic Cation Transporter (OCT/OCTN) Expression at Brain Barrier Sites: Focus on CNS Drug Delivery.
Betterton RD; Davis TP; Ronaldson PT
Handb Exp Pharmacol; 2021; 266():301-328. PubMed ID: 33674914
[TBL] [Abstract][Full Text] [Related]
13. Interactions of the active components of Punica granatum (pomegranate) with the essential renal and hepatic human Solute Carrier transporters.
Li Z; Wang K; Zheng J; Cheung FS; Chan T; Zhu L; Zhou F
Pharm Biol; 2014 Dec; 52(12):1510-7. PubMed ID: 25026340
[TBL] [Abstract][Full Text] [Related]
14. Role of Transporters in Central Nervous System Drug Delivery and Blood-Brain Barrier Protection: Relevance to Treatment of Stroke.
Brzica H; Abdullahi W; Ibbotson K; Ronaldson PT
J Cent Nerv Syst Dis; 2017; 9():1179573517693802. PubMed ID: 28469523
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption.
Shitara Y; Maeda K; Ikejiri K; Yoshida K; Horie T; Sugiyama Y
Biopharm Drug Dispos; 2013 Jan; 34(1):45-78. PubMed ID: 23115084
[TBL] [Abstract][Full Text] [Related]
16. The impact of solute carrier (SLC) drug uptake transporter loss in human and rat cryopreserved hepatocytes on clearance predictions.
Lundquist P; Lööf J; Sohlenius-Sternbeck AK; Floby E; Johansson J; Bylund J; Hoogstraate J; Afzelius L; Andersson TB
Drug Metab Dispos; 2014 Mar; 42(3):469-80. PubMed ID: 24396146
[TBL] [Abstract][Full Text] [Related]
17. Expression and Function of Organic Anion Transporting Polypeptides in the Human Brain: Physiological and Pharmacological Implications.
Schäfer AM; Meyer Zu Schwabedissen HE; Grube M
Pharmaceutics; 2021 Jun; 13(6):. PubMed ID: 34199715
[TBL] [Abstract][Full Text] [Related]
18. Uptake Transporters of the SLC21, SLC22A, and SLC15A Families in Anticancer Therapy-Modulators of Cellular Entry or Pharmacokinetics?
Brecht K; Schäfer AM; Meyer Zu Schwabedissen HE
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32806706
[TBL] [Abstract][Full Text] [Related]
19. Hepatic solute carrier transporters and drug therapy: Regulation of expression and impact of genetic variation.
Nies AT; Schaeffeler E; Schwab M
Pharmacol Ther; 2022 Oct; 238():108268. PubMed ID: 35995278
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and Toxicokinetics Roles of Membrane Transporters at Kidney Level.
Veiga-Matos J; Remião F; Motales A
J Pharm Pharm Sci; 2020; 23():333-356. PubMed ID: 32997956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
